文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2005 - 2014年挪威全科医疗中的2型糖尿病:危险因素控制有适度改善,但并发症筛查仍存在重大差距。

Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening.

作者信息

Bakke Åsne, Cooper John G, Thue Geir, Skeie Svein, Carlsen Siri, Dalen Ingvild, Løvaas Karianne Fjeld, Madsen Tone Vonheim, Oord Ellen Renate, Berg Tore Julsrud, Claudi Tor, Tran Anh Thi, Gjelsvik Bjørn, Jenum Anne Karen, Sandberg Sverre

机构信息

Department of Endocrinology, Stavanger University Hospital, Stavanger, Norway.

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

出版信息

BMJ Open Diabetes Res Care. 2017 Nov 8;5(1):e000459. doi: 10.1136/bmjdrc-2017-000459. eCollection 2017.


DOI:10.1136/bmjdrc-2017-000459
PMID:29177051
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5687527/
Abstract

OBJECTIVE: To assess the status of type 2 diabetes care in general practice and changes in the quality of care between 2005 and 2014, and to identify areas of diabetes care requiring improvement. RESEARCH DESIGN AND METHODS: Two cross-sectional surveys were performed that included patients with type 2 diabetes in selected areas (n=9464 in 2014, n=5463 in 2005). Quality of care was assessed based on key recommendations in national guidelines. Differences in clinical performance between 2005 and 2014 were assessed in regression models adjusting for age, sex, counties and clustering within general practices. RESULTS: Treatment targets were achieved in a higher proportion of patients in 2014 compared with 2005: hemoglobin A1c ≤7.0% (≤53 mmol/mol) in 62.8% vs 54.3%, blood pressure ≤135/80 mm Hg in 44.9% vs 36.6%, and total cholesterol ≤4.5 mmol/L in 49.9% vs 33.5% (all adjusted P≤0.001). Regarding screening procedures for microvascular complications, fewer patients had recorded an eye examination (61.0% vs 71.5%, adjusted P<0.001), whereas more patients underwent monofilament test (25.9% vs 18.7%, adjusted P<0.001). Testing for albuminuria remained low (30.3%) in 2014. A still high percentage were current smokers (22.7%). CONCLUSIONS: We found moderate improvements in risk factor control for patients with type 2 diabetes in general practice during the last decade, which are similar to improvements reported in other countries. We report major gaps in the performance of recommended screening procedures to detect microvascular complications. The proportion of daily smokers remains high. We suggest incentives to promote further improvements in diabetes care in Norway.

摘要

目的:评估全科医疗中2型糖尿病护理的现状以及2005年至2014年间护理质量的变化,并确定糖尿病护理中需要改进的领域。 研究设计与方法:进行了两项横断面调查,纳入选定地区的2型糖尿病患者(2014年n = 9464,2005年n = 5463)。根据国家指南中的关键建议评估护理质量。在对年龄、性别、县以及全科医疗中的聚类进行调整的回归模型中评估2005年和2014年临床绩效的差异。 结果:与2005年相比,2014年达到治疗目标的患者比例更高:糖化血红蛋白≤7.0%(≤53 mmol/mol)的患者比例为62.8% 对54.3%,血压≤135/80 mmHg的患者比例为44.9% 对36.6%,总胆固醇≤4.5 mmol/L的患者比例为49.9% 对33.5%(所有调整后P≤0.001)。关于微血管并发症的筛查程序,进行眼科检查的患者减少(61.0%对71.5%,调整后P<0.001),而进行单丝试验的患者增多(25.9%对18.7%,调整后P<0.001)。2014年白蛋白尿检测率仍然较低(30.3%)。当前吸烟者的比例仍然很高(22.7%)。 结论:我们发现过去十年中全科医疗中2型糖尿病患者的危险因素控制有适度改善,这与其他国家报告的改善情况相似。我们报告了在推荐的检测微血管并发症筛查程序的执行方面存在重大差距。日常吸烟者的比例仍然很高。我们建议采取激励措施以促进挪威糖尿病护理的进一步改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6d/5687527/923581cc1780/bmjdrc-2017-000459f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6d/5687527/923581cc1780/bmjdrc-2017-000459f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6d/5687527/923581cc1780/bmjdrc-2017-000459f01.jpg

相似文献

[1]
Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening.

BMJ Open Diabetes Res Care. 2017-11-8

[2]
Population, general practitioner and practice characteristics are associated with screening procedures for microvascular complications in Type 2 diabetes care in Norway.

Diabet Med. 2018-11-27

[3]
Quality of care for patients with type 2 diabetes in primary care in Norway is improving: results of cross-sectional surveys of 33 general practices in 1995 and 2005.

Diabetes Care. 2008-10-13

[4]
Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).

BMJ Open Diabetes Res Care. 2016-10-3

[5]
[Quality of diabetes care in Norwegian general practice].

Tidsskr Nor Laegeforen. 2008-11-20

[6]
IMPROVEMENTS IN METABOLIC CONTROL IN ADULTS WITH TYPE 2 DIABETES FOLLOWING REFERRAL TO A DIABETES CENTER, 2005-2010.

Endocr Pract. 2016-6

[7]
A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.

Cardiovasc J Afr. 2020

[8]

2017-7

[9]
Quality of Care in People With Diabetes

2018-8

[10]
Improving outcomes for patients with type 2 diabetes using general practice networks: a quality improvement project in east London.

BMJ Qual Saf. 2014-2

引用本文的文献

[1]
Young-onset type 2 diabetes and associations with high disability rate, low educational level and immigrant background: a study from Norwegian general practice.

BMJ Open. 2025-9-4

[2]
Effects on HbA1c of referral of type 2 diabetes patients to secondary care.

Scand J Prim Health Care. 2025-6

[3]
Academic Detailing Compared with Group Meetings to Change Drug Prescribing for Type 2 Diabetes-A Randomized Controlled Trial.

J Gen Intern Med. 2024-12

[4]
Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus.

Front Clin Diabetes Healthc. 2024-5-23

[5]
Decreasing lifetime prevalence of diabetes-related foot ulcers in Norway: repeated cross-sectional population-based surveys from the HUNT study (1995-2019).

Front Endocrinol (Lausanne). 2024

[6]
High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practice.

BMJ Open Diabetes Res Care. 2024-1-2

[7]
Insulin initiation in patients with type 2 diabetes is often delayed, but access to a diabetes nurse may help-insights from Norwegian general practice.

Scand J Prim Health Care. 2024-3

[8]
Evaluation of an interprofessional follow-up intervention among people with type 2 diabetes in primary care-A randomized controlled trial with embedded qualitative interviews.

PLoS One. 2023

[9]
Guideline-level monitoring, biomarker levels and pharmacological treatment in migrants and native Danes with type 2 diabetes: Population-wide analyses.

PLOS Glob Public Health. 2023-10-18

[10]
Academic detailing as a method to improve general practitioners' drug prescribing in type 2 diabetes: evaluation of changes in prescribing.

Scand J Prim Health Care. 2023-9

本文引用的文献

[1]
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.

Lancet Diabetes Endocrinol. 2017-3-30

[2]
9. Cardiovascular Disease and Risk Management.

Diabetes Care. 2017-1

[3]
Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).

BMJ Open Diabetes Res Care. 2016-10-3

[4]
Diabetes: Steno-2 - a small study with a big heart.

Nat Rev Endocrinol. 2016-12

[5]
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.

Diabetes Care. 2017-4

[6]
A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.

Health Technol Assess. 2016-8

[7]
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.

Diabetologia. 2016-11

[8]
Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.

Ann Intern Med. 2016-9-20

[9]
Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

Diab Vasc Dis Res. 2016-7

[10]
Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.

BMC Endocr Disord. 2016-2-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索